Literature DB >> 3486962

Pharmacokinetics of superselective intra-arterial and intravenous [11C]BCNU evaluated by PET.

J L Tyler, Y L Yamamoto, M Diksic, J Théron, J G Villemure, C Worthington, A C Evans, W Feindel.   

Abstract

The pharmacokinetics of i.v. and superselective intra-arterial carbon-11 1,3-bis-(2-chloroethyl)-1-nitrosourea ([11C]BCNU) were directly compared for the first time in ten patients with recurrent gliomas using positron emission tomography (PET). Intra-arterial administration of [11C]BCNU achieved concentrations of the drug in the tumor that averaged 50 times higher than with a comparable i.v. dose. These preliminary results suggest that the degree of early metabolic trapping of BCNU in tumor correlates with the clinical response to this chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3486962

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  27 in total

Review 1.  Positron emission tomography and the central nervous system.

Authors:  R O Robinson; C D Ferrie; M Capra; M N Maisey
Journal:  Arch Dis Child       Date:  1999-09       Impact factor: 3.791

Review 2.  Development of radiotracers for oncology--the interface with pharmacology.

Authors:  Rohini Sharma; Eric Aboagye
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

Review 3.  Uses and limitations of positron emission tomography in clinical pharmacokinetics/dynamics (Part II).

Authors:  L L Ponto; J A Ponto
Journal:  Clin Pharmacokinet       Date:  1992-04       Impact factor: 6.447

Review 4.  Molecular imaging in clinical trials.

Authors:  Debra Josephs; James Spicer; Michael O'Doherty
Journal:  Target Oncol       Date:  2009-09-21       Impact factor: 4.493

Review 5.  Super selective intra-arterial cerebral infusion of modern chemotherapeutics after blood-brain barrier disruption: where are we now, and where we are going.

Authors:  Randy S D'Amico; Deepak Khatri; Noah Reichman; Nitesh V Patel; Tamika Wong; Sherese R Fralin; Mona Li; Jason A Ellis; Rafael Ortiz; David J Langer; John A Boockvar
Journal:  J Neurooncol       Date:  2020-02-19       Impact factor: 4.130

6.  Relationship between drug delivery and the intra-arterial infusion rate of SarCNU in C6 rat brain tumor model.

Authors:  N Takeda; M Diksic
Journal:  J Neurooncol       Date:  1999-02       Impact factor: 4.130

Review 7.  Intraarterial drug delivery for glioblastoma mutiforme: Will the phoenix rise again?

Authors:  Shailendra Joshi; Jason A Ellis; Eugene Ornstein; Jeffrey N Bruce
Journal:  J Neurooncol       Date:  2015-06-25       Impact factor: 4.130

Review 8.  Brain tumors.

Authors:  K L Black; J C Mazziotta; D P Becker
Journal:  West J Med       Date:  1991-02

9.  Pharmacokinetics of 11C-labelled BCNU and SarCNU in gliomas studied by PET.

Authors:  S Mitsuki; M Diksic; T Conway; Y L Yamamoto; J G Villemure; W Feindel
Journal:  J Neurooncol       Date:  1991-02       Impact factor: 4.130

10.  Integrating Dynamic Positron Emission Tomography and Conventional Pharmacokinetic Studies to Delineate Plasma and Tumor Pharmacokinetics of FAU, a Prodrug Bioactivated by Thymidylate Synthase.

Authors:  Jing Li; Seongho Kim; Anthony F Shields; Kirk A Douglas; Christopher I McHugh; Jawana M Lawhorn-Crews; Jianmei Wu; Thomas J Mangner; Patricia M LoRusso
Journal:  J Clin Pharmacol       Date:  2016-11       Impact factor: 3.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.